Protocol for Long Duration Whole Body Hyperthermia in Mice
August 25th, 2012
11.3K views
This paper describes a protocol for whole body hyperthermia in mice that can stimulate fever like conditions up to 12-24 hr.
Overview
This paper describes a protocol for whole body hyperthermia in mice that can stimulate fever like conditions up to 12-24 hr.
Key Study Components
Area of Science
- Neuroscience
- Physiology
Background
- Whole body hyperthermia is a method used to induce fever-like conditions.
- Fever can play a role in immune response and disease models.
- Understanding the effects of hyperthermia can provide insights into physiological responses.
- This protocol aims to standardize the method for reproducibility in research.
Purpose of Study
- To develop a reliable protocol for inducing hyperthermia in mice.
- To assess the physiological effects of induced fever-like conditions.
- To facilitate research on immune responses and related mechanisms.
Methods Used
- Induction of whole body hyperthermia in mice.
- Monitoring of temperature and physiological responses.
- Assessment of duration and effects of hyperthermia.
- Comparison with control groups to evaluate outcomes.
Main Results
- Successful induction of fever-like conditions in mice.
- Duration of hyperthermia effects observed between 12-24 hours.
- Physiological responses documented during the study.
- Findings contribute to understanding fever mechanisms.
Conclusions
- The protocol provides a standardized method for inducing hyperthermia.
- Results support further research into fever's role in immune response.
- Future studies can build on this methodology for various applications.
Frequently Asked Questions
What is whole body hyperthermia?
Whole body hyperthermia is a treatment that raises the body temperature to induce fever-like conditions.
How long do the effects of hyperthermia last?
The effects can last between 12 to 24 hours, depending on the protocol used.
What are the potential applications of this protocol?
This protocol can be used to study immune responses and the physiological effects of fever.
Is this method reproducible?
Yes, the protocol aims to provide a standardized approach for reproducibility in research.
What species is used in this study?
The study uses mice as the model organism for inducing hyperthermia.
What are the key outcomes of this study?
Key outcomes include successful induction of fever-like conditions and documentation of physiological responses.
Executive Industry Relevance
Standardized whole body hyperthermia protocols in mice enable controlled simulation of fever-like states, supporting mechanistic studies of immune modulation and stress responses. Reliable induction and maintenance of hyperthermia are critical for evaluating therapeutic hypotheses and de-risking early-stage oncology and immunology targets. This capability strengthens translational continuity from preclinical models to disease-relevant system interrogation in biopharma R&D.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of immune and stress pathway activation under controlled hyperthermic conditions.
- Supports biological de-risking by clarifying fever-mediated mechanisms relevant to disease models.
- Facilitates predictive confidence in target selection for immunomodulatory and oncology programs.
Screening & Assay Development
- Provides a reproducible in vivo system for evaluating compound effects under fever-like stress.
- Supports assay standardization by ensuring uniform temperature elevation and exposure duration.
- Enables quantitative assessment of physiological and molecular responses to candidate interventions.
Translational & Preclinical Research
- Aligns preclinical models with disease-relevant fever states observed in clinical settings.
- Supports continuity from discovery through preclinical validation of immune and stress response modulators.
- Enables risk-adjusted advancement decisions based on translational biomarker responses to hyperthermia.
Pipeline & Workflow Integration
This protocol positions whole body hyperthermia as a foundational tool from early discovery through preclinical evaluation, particularly in immunology and oncology pipelines.
- Discovery Biology: Facilitates hypothesis testing on fever-mediated immune mechanisms and stress pathways.
- Screening: Provides a standardized in vivo context for reproducible compound evaluation under hyperthermic stress.
- Analytics: Enables quantitative measurement of physiological and molecular endpoints during and after hyperthermia exposure.
- Translational Research: Bridges preclinical findings with clinical fever phenomena for biomarker alignment.
- Enterprise Reuse: Establishes a reusable, validated protocol for diverse therapeutic area investigations.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in immune and stress response studies.
- Operational Value: Delivers standardized, reproducible, and scalable hyperthermia induction in preclinical models.
- Strategic Value: Improves go/no-go decision quality and capital efficiency by enabling robust target validation.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of immunomodulatory and oncology assets.
Implementation Considerations
- Requires expertise in animal handling and physiological monitoring for precise temperature control.
- Needs access to validated heating equipment and real-time core temperature measurement systems.
- Demands cross-team standardization to ensure reproducibility across studies and sites.
- May require adaptation for different mouse strains or disease models based on physiological variability.
- Careful management of hydration and animal welfare is essential during prolonged hyperthermia exposure.
Biopharma FAQs
Why does null hypothesis testing matter for hyperthermia-induced immune pathway validation?
Null hypothesis testing enables objective assessment of whether observed immune responses during whole body hyperthermia are statistically significant compared to controls. This rigor is essential for target validation and reducing false positives in early discovery.
How does independent variable isolation in hyperthermia cycles support discovery workflows?
Isolating hyperthermia exposure as the independent variable ensures that observed physiological and molecular changes are attributable to temperature elevation, supporting clear mechanistic insights in the discovery pipeline.
What do quantitative dependent variable measurements enable in hyperthermia studies?
Quantitative measurement of core temperature, physiological responses, and molecular markers enables robust comparison across experimental groups and informs data-driven advancement decisions in preclinical research.
Why are replication requirements critical for cross-functional hyperthermia studies?
Replication ensures that hyperthermia-induced effects are reproducible and reliable, facilitating cross-functional collaboration and confidence in data used for target validation and portfolio triage.
What statistical analysis capabilities are required before implementing hyperthermia protocols?
Statistical analysis must support comparison of physiological and molecular endpoints between hyperthermia and control groups, enabling rigorous evaluation of experimental outcomes and supporting enterprise-level decision making.
